The bioT3 Platform

Ralph V. Boccia, MD, FACP

Video Categories: PMO Interview with the Innovator Series: Volume 9

Dr. Boccia describes the components of the bioT3 platform and its clinical utility in identifying tumor type and actionable targets for therapy.
October 28, 2014

Approaches of Therapy for PV Treatment

Ruben A. Mesa, MD, Mayo Clinic, Scottsdale Arizona describes why the need for cytoreductive therapy is evolving Supported through funding from Incyte

November 24, 2014

Personalizing Cancer Treatment Based on Unique Genetic Profile

Gary Palmer, MD, explains how research is ahead of the physician and patient and the need to educate the physician and patient on all the information about DNA and what drives the cancer.